Literature DB >> 33909257

Bavachin enhances NLRP3 inflammasome activation induced by ATP or nigericin and causes idiosyncratic hepatotoxicity.

Nan Qin1,2, Guang Xu1, Yan Wang1,3, Xiaoyan Zhan1, Yuan Gao4, Zhilei Wang1, Shubin Fu1, Wei Shi1, Xiaorong Hou1, Chunyu Wang1, Ruisheng Li5, Yan Liu5, Jiabo Wang1, Haiping Zhao6, Xiaohe Xiao7,8, Zhaofang Bai9.   

Abstract

Psoraleae Fructus (PF) is a well-known traditional herbal medicine in China, and it is widely used for osteoporosis, vitiligo, and other diseases in clinical settings. However, liver injury caused by PF and its preparations has been frequently reported in recent years. Our previous studies have demonstrated that PF could cause idiosyncratic drug-induced liver injury (IDILI), but the mechanism underlying its hepatotoxicity remains unclear. This paper reports that bavachin isolated from PF enhances the specific stimuli-induced activation of the NLRP3 inflammasome and leads to hepatotoxicity. Bavachin boosts the secretion of IL-1β and caspase-1 caused by ATP or nigericin but not those induced by poly(I:C), monosodium urate crystal, or intracellular lipopolysaccharide. Bavachin does not affect AIM2 or NLRC4 inflammasome activation. Mechanistically, bavachin specifically increases the production of nigericin-induced mitochondrial reactive oxygen species among the most important upstream events in the activation of the NLRP3 inflammasome. Bavachin increases the levels of aspartate transaminase and alanine aminotransferase in serum and hepatocyte injury accompanied by the secretion of IL-1β via a mouse model of lipopolysaccharide-mediated susceptibility to IDILI. These results suggest that bavachin specifically enhances the ATP- or nigericin-induced activation of the NLRP3 inflammasome. Bavachin also potentially contributes to PF-induced idiosyncratic hepatotoxicity. Moreover, bavachin and PF should be evaded among patients with diseases linked to the ATP- or nigericin-mediated activation of the NLRP3 inflammasome, which may be a dangerous factor for liver injury.

Entities:  

Keywords:  IL-1β; NLRP3 inflammasome; Psoraleae Fructus; bavachin; caspase-1; idiosyncratic drug-induced liver injury

Year:  2021        PMID: 33909257     DOI: 10.1007/s11684-020-0809-2

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  58 in total

Review 1.  Inflammasome Complexes: Emerging Mechanisms and Effector Functions.

Authors:  Vijay A K Rathinam; Katherine A Fitzgerald
Journal:  Cell       Date:  2016-05-05       Impact factor: 41.582

2.  Modest inflammation enhances diclofenac hepatotoxicity in rats: role of neutrophils and bacterial translocation.

Authors:  Xiaomin Deng; Robert F Stachlewitz; Michael J Liguori; Eric A G Blomme; Jeffrey F Waring; James P Luyendyk; Jane F Maddox; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2006-09-21       Impact factor: 4.030

Review 3.  Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.

Authors:  Robert J Fontana
Journal:  Gastroenterology       Date:  2013-12-31       Impact factor: 22.682

4.  A mouse model of severe halothane hepatitis based on human risk factors.

Authors:  Christine M Dugan; Allen E MacDonald; Robert A Roth; Patricia E Ganey
Journal:  J Pharmacol Exp Ther       Date:  2010-02-02       Impact factor: 4.030

Review 5.  Mechanism and Regulation of NLRP3 Inflammasome Activation.

Authors:  Yuan He; Hideki Hara; Gabriel Núñez
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

6.  The Role of CD8 T Cells in Amodiaquine-Induced Liver Injury in PD1-/- Mice Cotreated with Anti-CTLA-4.

Authors:  Alastair Mak; Jack Uetrecht
Journal:  Chem Res Toxicol       Date:  2015-07-15       Impact factor: 3.739

7.  Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats.

Authors:  James P Luyendyk; Jane F Maddox; Gregory N Cosma; Patricia E Ganey; Gary L Cockerell; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2003-07-31       Impact factor: 4.030

Review 8.  Idiosyncratic drug-induced liver injury: an overview.

Authors:  S Hyder Hussaini; Elizabeth A Farrington
Journal:  Expert Opin Drug Saf       Date:  2007-11       Impact factor: 4.250

9.  Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha.

Authors:  Patrick J Shaw; Marie J Hopfensperger; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2007-08-19       Impact factor: 4.849

10.  Treatment of PD-1(-/-) mice with amodiaquine and anti-CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients.

Authors:  Imir G Metushi; M Anthony Hayes; Jack Uetrecht
Journal:  Hepatology       Date:  2015-02-23       Impact factor: 17.425

View more
  5 in total

1.  Eriodictyol and Homoeriodictyol Improve Memory Impairment in Aβ25-35-Induced Mice by Inhibiting the NLRP3 Inflammasome.

Authors:  Pengli Guo; Mengnan Zeng; Shengchao Wang; Bing Cao; Meng Liu; Yuhan Zhang; Jufang Jia; Qinqin Zhang; Beibei Zhang; Ru Wang; Xiaoke Zheng; Weisheng Feng
Journal:  Molecules       Date:  2022-04-12       Impact factor: 4.927

Review 2.  NLRP3 Inflammasome Pharmacological Inhibitors in Glycyrrhiza for NLRP3-Driven Diseases Treatment: Extinguishing the Fire of Inflammation.

Authors:  Zhilei Wang; Guang Xu; Zhiyong Li; Xiaohe Xiao; Jianyuan Tang; Zhaofang Bai
Journal:  J Inflamm Res       Date:  2022-01-19

Review 3.  The Role of Natural Products as Inhibitors of JAK/STAT Signaling Pathways in Glioblastoma Treatment.

Authors:  Hanieh Fahmideh; Hooriyeh Shapourian; Rasol Moltafeti; Chanour Tavakol; Razieh Forghaniesfidvajani; Hamidreza Zalpoor; Mohsen Nabi-Afjadi
Journal:  Oxid Med Cell Longev       Date:  2022-09-19       Impact factor: 7.310

Review 4.  Pharmacological effects of Chinese medicine modulating NLRP3 inflammasomes in fatty liver treatment.

Authors:  Tingting Liu; Guang Xu; Longxin Liang; Xiaohe Xiao; Yanling Zhao; Zhaofang Bai
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

5.  Anti-oxidative and anti-inflammatory activities of the ethanol extract of edible flower from Chimonanthus praecox.

Authors:  Yuan Kang; Zhuangzhuang Liu; Wenjing Li; Ximeng Li; Xiaoyu Zhang; Zhenlu Xu; Yuan Gao; Yun Qi
Journal:  Front Pharmacol       Date:  2022-09-27       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.